CS-505 (Pactimibe)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CS-505 (Pactimibe), covering 2012-01-18 to 2012-01-18. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Carotid Artery Disease. This Study is Also Known as CAPTIVATE. [Phase 2, Phase 3]